阿扎胞苷联合高三尖杉酯碱通过激活c-MYC/DDIT3/PUMA轴在急性髓系白血病中发挥协同效应
本研究通过细胞增殖、凋亡和克隆形成实验,探讨阿扎胞苷(AZA)联合高三尖杉酯碱(HHT)在急性髓系白血病(AML)中的协同效应及机制。结果显示两药联合在AML细胞中CI<0.9,显著抑制增殖和克隆形成、促进凋亡,并通过激活ISR信号通路调控c-MYC/DDIT3/PUMA轴发挥协同抗AML作用。
要点
- AZA联合HHT在AML细胞中具有协同效应,CI<0.9。
- 联合用药显著抑制U937和MV4-11细胞克隆形成并促进凋亡(P<0.001)。
- 协同作用通过激活ISR信号通路调控c-MYC/DDIT3/PUMA轴实现。
核心结论
- AZA联合HHT通过激活ISR信号通路、调控c-MYC/DDIT3/PUMA轴,抑制细胞增殖和促进细胞凋亡,发挥协同抗AML作用。
研究设计与样本
- 体外研究:采用细胞增殖、凋亡和克隆形成实验检测AZA与HHT的协同效应,并以协同效应指数(CI)计算协同作用。
- 通过转录组测序、通路抑制剂和基因敲降等方法探索两药协同机制。
主要发现
- 与单药相比,AZA+HHT可显著抑制AML细胞增殖,在U937、MV4-11和KG-1细胞中CI值均小于0.9。
- AZA+HHT能显著抑制U937(P<0.001)和MV4-11(P<0.001)细胞的克隆形成。
- AZA+HHT显著促进U937(P<0.001)和MV4-11(P<0.001)细胞凋亡。
- AZA联合HHT通过激活ISR信号通路介导DDIT3-PUMA依赖的AML细胞凋亡。
- AZA联合HHT可明显下调c-MYC蛋白,通过激活ISR信号通路调控c-MYC/DDIT3/PUMA轴促进细胞凋亡。
关键数值与推荐
- 协同效应判定:U937、MV4-11和KG-1细胞中CI值均小于0.9。
- 凋亡:U937细胞P<0.001,MV4-11细胞P<0.001(联合组 vs 单药对照组)。
- 克隆形成:U937细胞P<0.001,MV4-11细胞P<0.001(联合组 vs 单药对照组)。
临床怎么用
- 原文未据此给出临床推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Objective: This study aimed to explore the synergistic effect and underlying mechanism of azacitidine (AZA) in combination with homoharringtonine (HHT) in acute myeloid leukemia (AML) . Methods: The synergistic effects of AZA and HHT were examined by cell proliferation, apoptosis, and colony formation assays. The synergistic effects were calculated using the combination index (CI) , and the underlying mechanisms were explored using RNA sequencing, pathway inhibitors, and gene knockdown approaches. Results: Compared with the single-drug controls, AZA and HHT combination significantly induced cell proliferation arrest and showed a synergistic effect with CI < 0.9 in AML cells. In the combination group versus the single-drug controls, colony formation was significantly decreased, whereas apoptosis was significantly increased in U937 (P<0.001) and MV4-11 (P<0.001) cells. AZA and HHT combination activated the integrated stress response (ISR) signaling pathway and induced DDIT3-PUMA-dependent apoptosis in cells. Furthermore, it remarkably downregulated the expression of c-MYC. The combination also activated c-MYC/DDIT3/PUMA-mediated ISR signaling to induce synergy on apoptosis. The synergy of AZA+HHT on apoptosis was induced by activating c-MYC/DDIT3/PUMA-mediated ISR signaling. Conclusion: The combination of AZA and HHT exerts synergistic anti-AML effects by inhibiting cellular proliferation and promoting apoptosis through activation of the ISR signaling pathway via the c-MYC/DDIT3/PUMA axis. 目的: 探索阿扎胞苷(AZA)联合高三尖杉酯碱(HHT)治疗急性髓系白血病(AML)的协同效应及其分子机制。 方法: 采用细胞增殖、凋亡和克隆形成实验研究AZA联合HHT在AML中协同效应并计算两药协同效应指数(CI),通过转录组测序、通路抑制剂和基因敲降等方法,探索两药的协同机制。 结果: 与单药相比,AZA+ HHT可显著抑制AML细胞增殖,并具有显著的协同效应(U937、MV4-11和KG-1细胞中CI值均小于0.9);AZA+HHT能显著抑制U937(P<0.001)和MV4-11(P<0.001)细胞的克隆形成,并显著促进U937(P<0.001)和MV4-11(P<0.001)细胞凋亡。AZA联合HHT通过激活整合应激反应(ISR)信号通路介导DDIT3-PUMA依赖的AML细胞凋亡。AZA联合HHT可明显下调c-MYC蛋白,通过激活ISR信号通路,调控c-MYC/DDIT3/PUMA轴,促进细胞凋亡发挥协同抗AML作用。 结论: AZA联合HHT通过激活ISR信号通路,调控c-MYC/DDIT3/PUMA轴,抑制细胞增殖和促进细胞凋亡,发挥协同抗AML作用。.
引用
- Li J, Huang YQ, Zi J, et al. [Synergistic effect of azacitidine with homoharringtonine by activating the c-MYC/DDIT3/PUMA axis in acute myeloid leukemia]. Zhonghua Xue Ye Xue Za Zhi. 2023. PMID: 38503523. doi:10.3760/cma.j.issn.0253-2727.2023.12.006
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。